+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Urological Disorders Drugs Market Research Reports

Hydroxyzine Imine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Hydroxyzine Imine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 117 Pages
  • Global
From
Overactive Bladder Treatment Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027) - Product Thumbnail Image

Overactive Bladder Treatment Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Uropathy Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Uropathy Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 115 Pages
  • Global
From
Urinary Tract Infection (UTI) Treatment Market 2021-2025 - Product Thumbnail Image

Urinary Tract Infection (UTI) Treatment Market 2021-2025

  • Report
  • November 2021
  • 120 Pages
  • Global
From
Stress urinary incontinence Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Stress urinary incontinence Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Interstitial Cystitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Interstitial Cystitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • June 2022
  • 62 Pages
  • Global
From
Overactive Bladder - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Overactive Bladder - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 130 Pages
  • Global
From
Overactive Bladder - Epidemiology Forecast to 2030 - Product Thumbnail Image

Overactive Bladder - Epidemiology Forecast to 2030

  • Report
  • September 2021
  • 49 Pages
  • Global
From
Cefaclor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type - Product Thumbnail Image

Cefaclor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type

  • Report
  • January 2024
  • 131 Pages
  • Global
From
Urethritis Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Urethritis Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 105 Pages
  • Global
From
Acetohydroxamic Acid Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Acetohydroxamic Acid Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 99 Pages
  • Global
From
US Urinary Incontinence Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Urinary Incontinence Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Overactive Bladder Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Overactive Bladder Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Urinary Tract Infections Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Urinary Tract Infections Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Overactive Bladder Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Overactive Bladder Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
US Urinary Tract Infections Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Urinary Tract Infections Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Urinary Incontinence Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Urinary Incontinence Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Overactive Bladder Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Overactive Bladder Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
Ascorbic Acid Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region - Product Thumbnail Image

Ascorbic Acid Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region

  • Report
  • February 2024
  • 217 Pages
  • Global
Sodium Bicarbonate Market - Forecasts from 2021 to 2026 - Product Thumbnail Image

Sodium Bicarbonate Market - Forecasts from 2021 to 2026

  • Report
  • April 2021
  • Global
From
Loading Indicator

The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them. Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more